Press Room

DSKB Nyt - suPAR is a new Prognostic Biomarker in Clinical Routine

Denmark, September 1, 2015.

In the latest issue of DSKB Nyt no. 2/2015, Dansk Selskab for Klinisk Biokemi, is an article on suPAR - a new prognostic biomarker in clinical routine at Copenhagen University Hospital, Hvidovre, Denmark.

suPAR has since november 2013 been measured on all patients upon admission to the Emergency Department at Hvidovre Hospital using the suPARnostic® AUTO Flex Elisa assay, automated on the BEP2000 platform and analysed once every day. Preliminary results show, that suPAR is strongly correlated with mortality (30- and 90-days), and that suPAR kan help identify the patients at risk who should receive increased clinical attention.

In order for clinicians at the Emergency Department to be able to use the suPAR results even better in the clinical assessment of the patient, they need to receive the suPAR results faster, together with other test results taken.

Hvidovre Hospitals Clinical Biochemical Department is therefore working on developing a new suPAR immunoturbidimetry assay on the COBAS 6000, to bring down the analysis time.

More information in the article (in Danish) here;
"Indførelse af suPAR som ny prognostisk biomarkør i klinisk rutine"


Contact us

virogates logo2
Blokken 45

3460 Birkerød

Phone +45 21 13 13 36
Skype: virogates
CVR No.: 25734033

 in-2  tw-2